Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

BionicVEST-2 · EUROPEAN DEVELOPMENT OF A FIRST COMMERCIAL BIONIC VESTIBULAR IMPLANT FOR VESTIBULAR DYSFUNCTION - 2

HORIZONStatus: SIGNED1 September 202331 August 2026EU funding €2,498,938Call HORIZON-EIC-2022-TRANSITION-01

In this project we present a solution to restore balance and prevent falls through vestibular implantation and electrical stimulation of the otolith organ. Worldwide, about 684.000 individuals die from falls each year and 37.3 million falls require medical attention. The medical cost for treating falls in the EU is approximately 25 billion euros each year. This number can be expected to go up since the elderly population is growing. One of the most important causes of falling is vestibular dysfunction. Therefore, restoration of the vestibular function may revolutionize this field because it offers a whole new treatment paradigm. The foundation of vestibular dysfunction treatment was laid during the Bionic\VEST H2020 FET-OPEN project funded by the EU. This FET-OPEN project obtained spectacular results and showed that the successful restoration of vestibular function through electrical stimulation of the otolith organ is possible. Where there was no suitable treatment before, balance improvement and even restoration is feasible. The result of this first Bionic\VEST FET-OPEN project was a proof-of-principle on humans with a prototype otolith vestibular implant. To unlock the full commercial potential of this vestibular restorative therapy, the new Bionic\VEST-2 project will focus on the path to commercialization of the Bionic\VEST implant. This requires improvements in the implant technology to achieve its full potential on the market. A pivotal clinical trial will have to be run with the new device to provide evidence for the safety and efficacy of the final implant, as well as gather data for health economics. Further, novel diagnostic clinical tools will be developed to identify the patients that can benefit from this technology promptly. In-depth market research and an elaborated business case should confirm that the vestibular implant will bring the long-awaited solution for vestibular disorders and ameliorate the enormous societal impact of this problem.

Consortium · 6 organisations

coordinator

COCHLEAR BENELUX NV

BE · €857,500

participant

DIENST NEUS-KEEL-OOR SINT-AUGUSTINUS ANTWERPEN

BE · €437,500

participant

SERVICIO CANARIO DE LA SALUD

ES · €547,500

participant

STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM

NL · €322,813

participant

UNIVERSIDAD DE NAVARRA

ES · €333,625

thirdParty

COCHLEAR FRANCE SAS

FR

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.